Our SVP Alice Hsu presented on AI-powered clinical trials at DIA 2024, showcasing AuroraPrime's transformative features. CEO Sharon Chen shared strategic insights as a panel expert, highlighting our innovative approaches.

The DIA Singapore Annual Meeting 2024, held on July 16-17, was a milestone event for the life sciences sector. AlphaLife Sciences was honored to participate, showcasing our cutting-edge innovations and engaging with industry leaders.

Our Senior VP of Clinical Services, Alice Hsu, delivered a captivating presentation on "Fast-track Clinical Trials with Leading Generative AI-powered Digital Solutions." She highlighted key features of our AuroraPrime platform, including Protocol Synopsis Design, Protocol Writing, CSR Writing, and Safety Narratives Generation, demonstrating how our AI solutions transform clinical research by enhancing efficiency and success.

Adding to the event's success, our CEO, Sharon Chen, joined a distinguished panel of experts, addressing critical questions and sharing strategic insights that underscored our innovative approaches in clinical research.

We are grateful to everyone who visited our booth and engaged with us. Our participation underscored our commitment to advancing clinical research and fostering meaningful collaborations. Stay tuned for more updates as we continue to lead in clinical research and beyond.

Thank you for your support!